MAPC treatment of brain injuries and diseases
US11351202B2 · kind B2 · utility
1Cited by
25References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 20, 2017 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Dec 20, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/0607
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.